Cargando…

Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events

IMPORTANCE: Persons with opioid use disorder (OUD) and co-occurring alcohol use disorder (AUD) are understudied and undertreated. It is unknown whether the use of medications to treat OUD is associated with reduced risk of alcohol-related morbidity. OBJECTIVE: To determine whether the use of OUD med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Kevin Y., Presnall, Ned, Mintz, Carrie M., Borodovsky, Jacob T., Bhat, Nisha R., Bierut, Laura J., Grucza, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905500/ https://www.ncbi.nlm.nih.gov/pubmed/33625511 http://dx.doi.org/10.1001/jamanetworkopen.2021.0061

Ejemplares similares

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder
por: Mintz, Carrie M., et al.
Publicado: (2022)

Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015
por: Xu, Kevin Y., et al.
Publicado: (2020)

Association between recent overdose and chronic pain among individuals in treatment for opioid use disorder
por: Hartz, Sarah M., et al.
Publicado: (2022)

Co-Occurring Risk Factors for Alcohol Dependence and Habitual Smoking: Update on Findings From the Collaborative Study on the Genetics of Alcoholism
por: Grucza, Richard A., et al.
Publicado: (2006)

Association Between Workplace Absenteeism and Alcohol Use Disorder From the National Survey on Drug Use and Health, 2015-2019
por: Parsley, Ian C., et al.
Publicado: (2022)

Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention’s Opioid Prescribing Guidelines
por: Scherrer, Jeffrey F., et al.
Publicado: (2020)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Characterizing the Followers and Tweets of a Marijuana-Focused Twitter Handle
por: Cavazos-Rehg, Patricia, et al.
Publicado: (2014)

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk
por: Tardelli, Vitor, et al.
Publicado: (2023)

Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment
por: Binswanger, Ingrid A., et al.
Publicado: (2022)

Association of Racial Disparity of Cannabis Possession Arrests Among Adults and Youths With Statewide Cannabis Decriminalization and Legalization
por: Sheehan, Brynn E., et al.
Publicado: (2021)

Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions
por: Scherrer, Jeffrey F., et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina
por: DiPrete, Bethany L., et al.
Publicado: (2022)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
por: Scherrer, Jeffrey F., et al.
Publicado: (2022)

Trajectories of Opioid Use Following First Opioid Prescription in Opioid-Naive Youths and Young Adults
por: Wilson, J. Deanna, et al.
Publicado: (2021)

Does familial risk for alcohol use disorder predict alcohol hangover?
por: Stephens, Richard, et al.
Publicado: (2017)

Association of US Medical Marijuana Laws With Nonmedical Prescription Opioid Use and Prescription Opioid Use Disorder
por: Segura, Luis E., et al.
Publicado: (2019)

Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019
por: Mauro, Pia M., et al.
Publicado: (2022)

Associations of Parental Marijuana Use With Offspring Marijuana, Tobacco, and Alcohol Use and Opioid Misuse
por: Madras, Bertha K., et al.
Publicado: (2019)

Alcohol or Benzodiazepine Co-involvement With Opioid Overdose Deaths in the United States, 1999-2017
por: Tori, Marco E., et al.
Publicado: (2020)

Marijuana, Opioid, and Alcohol Use Among Pregnant and Postpartum Individuals Living With HIV in the US
por: Yee, Lynn M., et al.
Publicado: (2021)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
por: Haffajee, Rebecca L., et al.
Publicado: (2019)

Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails
por: Sufrin, Carolyn, et al.
Publicado: (2022)

Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
por: Bykov, Katsiaryna, et al.
Publicado: (2020)

Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events
por: Kurteva, Siyana, et al.
Publicado: (2021)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Integrating Opioid Use Disorder Treatment Into Primary Care Settings
por: Austin, Elizabeth J., et al.
Publicado: (2023)

Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation
por: Palumbo, Sarah A., et al.
Publicado: (2020)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

184 Exploring facility level differences in medication-based treatment of OUD
por: Thornton, Vera, et al.
Publicado: (2023)

Association of Intraoperative Opioid Administration With Postoperative Pain and Opioid Use
por: Santa Cruz Mercado, Laura A., et al.
Publicado: (2023)

Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic
por: Tilhou, Alyssa Shell, et al.
Publicado: (2022)

Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder
por: Patrick, Stephen W., et al.
Publicado: (2020)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder
por: Joudrey, Paul J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_40db1pplec73lm36a8tslhtqhm